The Vanguard Group, Inc. recently announced the acquisition of new stake in NVIDIA Corp (NASDAQ:NVDA). The institutional investor has increased its shareholding in the Technology company by 1.14% to 193.39 million shares with purchase of 2.18 million shares. This fresh investment now brings its stake to 7.83% valued currently at $95.77 billion. In addition, BlackRock Fund Advisors raised its holdings by 10745.0 to 115.86 million shares. And Geode Capital Management LLC has lifted its position by 2.22% or 1.05 million shares – to 48.51 million shares.
Currently, there are 2.47B common shares owned by the public and among those 2.37B shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 239 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 45 of these insider trades were purchases, accounting for 999,643 shares. Insider sales of the common stock occurred on 194 occasions, with total insider shares sold totaling 1,507,756 shares.
The top 3 mutual fund holders in NVIDIA Corp are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and SPDR S&P 500 ETF Trust. Vanguard Total Stock Market ETF owns 73.65 million shares of the company’s stock, all valued at over $36.47 billion. The company bought an additional 0.1 million shares recently to bring their total holdings to about 2.98% of the shares outstanding. Vanguard 500 Index Fund bought 0.11 million shares to see its total holdings expand to 60.31 million shares valued at over $29.87 billion and representing 2.44% of the shares outstanding. SPDR S&P 500 ETF Trust sold -0.17 million shares to bring its total holdings to over 30.22 million shares at a value of $14.97 billion. SPDR S&P 500 ETF Trust now owns shares totaling to 1.22% of the shares outstanding.
However, the script later moved the day high at 617.82, down -0.95%. The company’s stock has a 5-day price change of 2.59% and 46.08% over the past three months. NVDA shares are trading 23.24% year to date (YTD), with the 12-month market performance up to 215.85% higher. It has a 12-month low price of $189.50 and touched a high of $628.49 over the same period. NVDA has an average intraday trading volume of 42.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 12.80%, 20.67%, and 41.98% respectively.
Institutional ownership of NVIDIA Corp (NASDAQ: NVDA) shares accounts for 67.50% of the company’s 2.47B shares outstanding. Mutual fund holders own 39.09%, while other institutional holders and individual stakeholders account for 4.07% and 28.86% respectively.
It has a market capitalization of $1507.47B and a beta (3y monthly) value of 1.69. The stock’s trailing 12-month PE ratio is 80.58, while the earnings-per-share (ttm) stands at $7.57. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.86% over the week and 2.85% over the month.
Analysts forecast that NVIDIA Corp (NVDA) will achieve an EPS of $GraniteShares 1.5x Short NVDA D for the current quarter, $24.87 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Invitae Corporation while analysts give the company a high EPS estimate of $Vanda Pharmaceuticals Inc.. Comparatively, EPS for the current quarter was $Tidal ETF Trust II YieldMax NVD a year ago. Earnings per share for the fiscal year are expected to increase by 268.61%, and 70.99% over the next financial year.
Looking at the support for the NVDA, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on January 23, 2024, with the firm’s price target at $775.
